[en] Converging evidence made clear that declining brain energetics contribute to aging and are implicated in the initiation and progression of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Indeed, both pathologies involve instances of hypometabolism of glucose and oxygen in the brain causing mitochondrial dysfunction, energetic failure and oxidative stress. Importantly, recent evidence suggests that astrocytes, which play a key role in supporting neuronal function and metabolism, might contribute to the development of neurodegenerative diseases. Therefore, exploring how the neuro-supportive role of astrocytes may be impaired in the context of these disorders has great therapeutic potential. In the following, we will discuss some of the so far identified features underlining the astrocyte-neuron metabolic crosstalk. Thereby, special focus will be given to the role of mitochondria. Furthermore, we will report on recent advancements concerning iPSC-derived models used to unravel the metabolic contribution of astrocytes to neuronal demise. Finally, we discuss how mitochondrial dysfunction in astrocytes could contribute to inflammatory signaling in neurodegenerative diseases.
Disciplines :
Biochimie, biophysique & biologie moléculaire
Auteur, co-auteur :
MULICA, Patrycja ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Molecular and Functional Neurobiology
GRÜNEWALD, Anne ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Molecular and Functional Neurobiology
Pereira, Sandro L.
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective.
Date de publication/diffusion :
2021
Titre du périodique :
Frontiers in Endocrinology
eISSN :
1664-2392
Maison d'édition :
Frontiers Media S.A., Suisse
Volume/Tome :
12
Pagination :
668517
Peer reviewed :
Peer reviewed vérifié par ORBi
Projet FnR :
FNR13688526 - Contribution Of Astrocyte Metabolism To Synucleinopathy In Parkinson'S Disease., 2019 (01/09/2020-31/08/2023) - Anne Grünewald